BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,502 | -9.7% | 2,716 | +9.0% | 0.03% | -7.1% |
| Q2 2023 | $113,536 | -84.7% | 2,492 | -86.4% | 0.03% | -85.4% |
| Q1 2023 | $742,248 | -9.8% | 18,300 | +13.3% | 0.19% | -11.9% |
| Q4 2022 | $823,115 | -14.5% | 16,149 | -9.7% | 0.22% | -23.0% |
| Q3 2022 | $963,000 | -8.7% | 17,885 | +8.9% | 0.28% | -3.1% |
| Q2 2022 | $1,055,000 | -17.6% | 16,425 | -0.5% | 0.29% | -5.5% |
| Q1 2022 | $1,280,000 | -14.2% | 16,512 | -4.9% | 0.31% | -11.0% |
| Q4 2021 | $1,491,000 | +6.9% | 17,365 | +0.1% | 0.35% | -2.3% |
| Q3 2021 | $1,395,000 | +5.6% | 17,347 | +5.7% | 0.36% | +8.2% |
| Q2 2021 | $1,321,000 | +1.0% | 16,405 | +5.8% | 0.33% | +1.2% |
| Q1 2021 | $1,308,000 | +10.9% | 15,511 | +5.6% | 0.32% | +3.8% |
| Q4 2020 | $1,179,000 | +1.5% | 14,695 | +1.7% | 0.31% | -9.3% |
| Q3 2020 | $1,162,000 | -2.2% | 14,455 | +4.8% | 0.34% | -9.2% |
| Q2 2020 | $1,188,000 | +21.6% | 13,794 | +14.7% | 0.38% | -3.1% |
| Q1 2020 | $977,000 | -19.8% | 12,030 | -17.4% | 0.39% | +2.6% |
| Q4 2019 | $1,218,000 | +6.1% | 14,560 | +10.9% | 0.38% | -0.5% |
| Q3 2019 | $1,148,000 | -1.8% | 13,130 | -8.0% | 0.38% | -1.8% |
| Q2 2019 | $1,169,000 | -9.3% | 14,275 | -9.9% | 0.39% | -11.4% |
| Q1 2019 | $1,289,000 | +31.1% | 15,850 | +6.1% | 0.44% | +17.0% |
| Q4 2018 | $983,000 | -11.0% | 14,934 | +4.3% | 0.38% | +0.5% |
| Q3 2018 | $1,104,000 | +6.0% | 14,317 | +1.5% | 0.37% | +0.8% |
| Q2 2018 | $1,042,000 | +13.1% | 14,108 | -0.4% | 0.37% | -20.4% |
| Q1 2018 | $921,000 | +0.7% | 14,166 | 0.0% | 0.47% | +3.8% |
| Q4 2017 | $915,000 | +0.5% | 14,166 | -2.4% | 0.45% | -2.8% |
| Q3 2017 | $910,000 | +3.5% | 14,516 | -0.1% | 0.46% | +17.0% |
| Q2 2017 | $879,000 | +17.0% | 14,532 | +0.2% | 0.40% | -12.8% |
| Q1 2017 | $751,000 | +16.8% | 14,500 | 0.0% | 0.45% | +18.9% |
| Q4 2016 | $643,000 | -6.8% | 14,500 | 0.0% | 0.38% | -9.1% |
| Q3 2016 | $690,000 | +5.7% | 14,500 | +0.4% | 0.42% | +6.6% |
| Q2 2016 | $653,000 | +9.9% | 14,443 | -0.1% | 0.39% | +6.5% |
| Q1 2016 | $594,000 | +8.2% | 14,464 | +0.4% | 0.37% | +7.6% |
| Q4 2015 | $549,000 | -48.6% | 14,408 | -5.8% | 0.34% | -45.1% |
| Q2 2015 | $1,069,000 | -6.7% | 15,295 | -8.6% | 0.62% | -11.2% |
| Q1 2015 | $1,146,000 | -9.2% | 16,731 | -2.9% | 0.70% | -9.5% |
| Q4 2014 | $1,262,000 | +2.1% | 17,231 | 0.0% | 0.78% | +5.0% |
| Q3 2014 | $1,236,000 | -1.0% | 17,231 | -0.2% | 0.74% | -2.0% |
| Q2 2014 | $1,248,000 | -5.4% | 17,263 | -3.7% | 0.76% | -12.4% |
| Q1 2014 | $1,319,000 | +4.3% | 17,935 | -1.4% | 0.86% | +5.1% |
| Q4 2013 | $1,265,000 | +2.8% | 18,196 | -2.9% | 0.82% | -3.3% |
| Q3 2013 | $1,231,000 | -6.5% | 18,744 | -1.3% | 0.85% | -6.7% |
| Q2 2013 | $1,316,000 | – | 18,992 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |